UCLA Clinical and Translational Science Institute is a dynamic partnership of four institutions—Cedars-Sinai Medical Center, Charles Drew University of Medicine and Science, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, and the UCLA-Westwood. Its mission is to bring UCLA innovations to bear on the greatest health needs of Los Angeles and the nation.
UCLA CTSI is organized into nine program areas that support a wide range of research. CTSI investigators are tackling the most pressing challenges in such areas as addiction, cancer, disease prevention, heart disease, HIV, mental health, patient safety, stroke and women’s health.
UCLA CTSI supports this work by providing seed grants, training, and access to specialized expertise or resources—such as statisticians, computer databases, clinical tests, gene sequencers and other sophisticated, high-tech equipment, and study volunteers.
To achieve its mission, UCLA CTSI has formed collaborations with community organizations, health clinics and schools. These research partnerships ensure that our discoveries are relevant to the health needs of Los Angeles.
UCLA CTSI is one of 60 such institutes to receive a Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences, part of the National Institutes of Health (NIH). The NIH created the CTSAs to enhance the translation of basic research into drugs, medical devices, tools and interventions that improve health. Click here for more information about the national CTSA network.
The vision of the UCLA CTSI is a healthier Los Angeles County. We invite you to explore this website to learn more about UCLA CTSI.
